Harrow partners with cencora to launch “harrow cares” program, making iheezo® and triesence® more accessible and affordable for retina specialists and their patients

Nashville, tenn.--(business wire)---- $hrow--harrow (nasdaq: hrow), a leading north american eyecare pharmaceutical company, today announced the launch of its “harrow cares” program through a strategic partnership with cencora (nyse: cor). harrow cares delivers a comprehensive suite of high‑quality access and affordability services, enhancing support for retina specialists, their staff, and patients. through a state-of-the-art patient support services hub, harrow cares ensures seamless enrollment, rapid.
COR Ratings Summary
COR Quant Ranking